Opioid Withdrawal Timeline
A detailed, medically informed guide to what happens when you stop using opioids, from the first hours through long-term recovery.
What to Expect During Opioid Withdrawal
Understanding the opioid withdrawal timeline is one of the most important things you can do to prepare for recovery. Withdrawal is the process your body goes through when it no longer receives the opioid it has become dependent on. The experience is often described as one of the most physically uncomfortable states a person can endure, which is precisely why so many people continue using opioids even when they desperately want to stop. Fear of withdrawal is one of the most significant barriers to entering treatment. CRITICAL SAFETY NOTE: Opioid withdrawal, while rarely life-threatening in otherwise healthy adults, can be extremely uncomfortable and medically complex. Complications including severe dehydration, electrolyte imbalances, and aspiration can occur, particularly in people with underlying health conditions. Most critically, the period during and immediately after withdrawal carries the highest risk of fatal overdose, because tolerance drops rapidly and returning to a previous dose can be lethal. Always seek professional medical guidance before attempting to discontinue opioid use. Call SAMHSA at 1-800-662-4357 for free, confidential treatment referrals. The timeline presented here is a general guide based on clinical research and reflects typical patterns for short-acting and long-acting opioids. Your individual experience will depend on several factors: the specific opioid you have been using, the duration and amount of use, your method of administration, your overall health, your genetics, and whether you have medical support. Medication-assisted treatment with buprenorphine or methadone can dramatically reduce or eliminate withdrawal symptoms entirely, which is one of the primary reasons these treatments are considered the standard of care for opioid use disorder. This page is intended to educate and prepare, not to serve as a substitute for medical advice. If you are considering stopping opioid use, please do so under the guidance of a healthcare provider who specializes in addiction medicine.
What Causes Opioid Withdrawal?
Opioid withdrawal is a predictable physiological response that occurs when the brain and body, which have adapted to the constant presence of opioids, are suddenly deprived of them. To understand withdrawal, it helps to understand what opioids do to the brain. Opioids bind to mu-opioid receptors located throughout the brain, spinal cord, and gastrointestinal tract. These receptors naturally interact with your body's own opioid-like chemicals, called endorphins, to regulate pain, mood, digestion, and basic autonomic functions. When you introduce external opioids, these receptors are activated far more intensely than endorphins alone could achieve, producing powerful pain relief and euphoria. With repeated use, the brain adapts. It reduces its own endorphin production and decreases the number and sensitivity of opioid receptors, a process called downregulation. This is the basis of tolerance: you need more of the drug to achieve the same effect because your brain is working to counterbalance the opioid's presence. At the same time, other neurotransmitter systems, particularly norepinephrine in a brain region called the locus coeruleus, are suppressed by opioids. When the opioid is suddenly removed, these suppressed systems rebound dramatically. The locus coeruleus floods the body with norepinephrine, producing many of the hallmark symptoms of withdrawal: anxiety, muscle cramping, sweating, nausea, vomiting, diarrhea, and elevated heart rate and blood pressure. In essence, opioid withdrawal is your nervous system overreacting to the absence of a substance it has reorganized itself around. This is not a sign of weakness. It is a predictable, neurochemical process that affects every person who develops physical opioid dependence, regardless of how they got there.
Mu-Opioid Receptor Adaptation
The brain reduces its natural endorphin production and downregulates opioid receptors in response to chronic opioid exposure, creating a state where the drug is required just to feel normal.
Norepinephrine Rebound
Opioids suppress the locus coeruleus, a brain region that produces norepinephrine. When opioids are removed, this system floods the body with norepinephrine, driving many withdrawal symptoms including anxiety, sweating, cramping, and elevated heart rate.
Tolerance and Dependence
As tolerance builds, the brain becomes physically dependent on the opioid to maintain normal function. Withdrawal symptoms are the expression of this dependence when the drug is no longer available.
Individual Variation
The severity and duration of withdrawal varies based on the specific opioid used, the duration and amount of use, genetics, overall health, co-occurring conditions, and whether medical support is provided.
The Acute Withdrawal Timeline
Acute opioid withdrawal follows a relatively predictable pattern, though the exact timing depends heavily on the type of opioid used. Short-acting opioids like heroin, oxycodone (immediate release), and hydrocodone typically produce withdrawal symptoms within 8 to 24 hours after the last dose, with peak intensity occurring between 36 and 72 hours and gradual resolution over 5 to 10 days. Long-acting opioids like methadone and extended-release formulations produce a delayed onset, with symptoms beginning 24 to 72 hours after the last dose, peaking later, and potentially lasting 2 to 3 weeks at significant intensity. Fentanyl presents a unique challenge because it is highly lipophilic, meaning it accumulates in body fat and can be released unpredictably, sometimes causing delayed or prolonged withdrawal patterns. The Clinical Opiate Withdrawal Scale (COWS) is a standardized tool that medical professionals use to assess withdrawal severity by measuring symptoms like resting pulse rate, sweating, restlessness, pupil size, bone or joint aches, runny nose, gastrointestinal upset, tremor, yawning, anxiety, and goosebumps. This scale guides treatment decisions, particularly around when to initiate buprenorphine treatment, which requires the patient to be in at least moderate withdrawal to avoid precipitated withdrawal, a sudden and severe worsening of symptoms caused by buprenorphine displacing full agonist opioids from receptors. Understanding this timeline is essential for preparation, but it should not be used as a guide for self-managing withdrawal. Medical supervision provides access to medications and monitoring that can make the experience dramatically more manageable and significantly safer.
Early Symptoms (8-24 hours for short-acting opioids)
Anxiety, restlessness, muscle aches, increased tearing and runny nose, excessive yawning, insomnia, and sweating. These early symptoms signal the beginning of norepinephrine rebound and feel like an intensifying flu.
Peak Symptoms (36-72 hours for short-acting opioids)
Severe abdominal cramping, nausea, vomiting, diarrhea, dilated pupils, goosebumps, rapid heartbeat, elevated blood pressure, intense muscle and bone pain, severe insomnia, and overwhelming cravings. This is typically the most physically intense period.
Gradual Resolution (Days 5-10 for short-acting opioids)
Physical symptoms begin to subside in intensity and frequency. Lingering fatigue, muscle aches, insomnia, and irritability may persist. Appetite slowly returns. Psychological symptoms including depression, anxiety, and cravings often become more prominent as acute physical distress recedes.
Extended Timeline for Long-Acting Opioids
Methadone and extended-release opioid formulations produce a slower onset of withdrawal, beginning 24-72 hours after the last dose, with a more gradual peak and a longer total duration that can extend to 2-3 weeks of significant symptoms.
Track your opioid-free days with Sobrius
Use Sobrius alongside your medical treatment to see your recovery progress grow, one day at a time. Free on the App Store and Google Play.
Post-Acute Withdrawal Syndrome (PAWS)
Beyond the acute withdrawal phase, many people recovering from opioid dependence experience post-acute withdrawal syndrome, commonly referred to as PAWS. This is a prolonged phase of recovery that can last weeks, months, or in some cases up to a year or more after the last opioid use. PAWS occurs because while acute withdrawal reflects the immediate rebound of the nervous system, the brain's reward circuitry, stress response systems, and neurotransmitter balance take much longer to fully normalize. PAWS is characterized by symptoms that come and go in waves rather than being constantly present. Common symptoms include persistent low mood or depressive episodes, anxiety, irritability, difficulty concentrating and memory problems, sleep disturbances, reduced motivation, fatigue, and intermittent cravings that can arise suddenly and with significant intensity. Many people in early recovery describe feeling emotionally flat, as though the ability to experience pleasure has been turned down or switched off. This phenomenon, called anhedonia, is a direct result of the brain's dopamine system slowly recovering from opioid-induced changes. PAWS is one of the most underappreciated challenges in opioid recovery. People who are not prepared for it may interpret the lingering depression and cravings as evidence that recovery is not working, when in fact these symptoms are a normal part of the healing process. Education about PAWS, continued therapeutic support, and tracking tools like Sobrius that help you observe gradual improvement over time are all important components of navigating this phase successfully. Exercise, proper nutrition, stress management, and social connection are the most effective non-pharmacological interventions for PAWS symptoms.
Mood Instability
Waves of depression, anxiety, and irritability that come and go unpredictably. These mood fluctuations are caused by the gradual recalibration of neurotransmitter systems and typically decrease in frequency and intensity over months.
Anhedonia
A reduced ability to feel pleasure from activities that would normally be enjoyable. This is one of the most distressing PAWS symptoms and is directly related to the slow recovery of the dopamine reward system after chronic opioid use.
Cognitive Difficulties
Problems with concentration, memory, and decision-making that can persist for weeks to months. These cognitive effects reflect the brain's ongoing neuroplastic recovery and typically improve steadily with sustained abstinence.
Sleep Disturbances
Insomnia, disrupted sleep architecture, and vivid dreams can persist long after acute withdrawal resolves. Opioids profoundly affect sleep regulation, and restoring healthy sleep patterns is one of the slower aspects of neurological recovery.
Intermittent Cravings
Cravings during PAWS can arise suddenly, often triggered by stress, environmental cues, or emotional states. While less constant than during acute withdrawal, individual PAWS cravings can still be intensely powerful and require active coping strategies.
Medical Support and Treatment Options
The most important message about opioid withdrawal is that you do not have to endure it unassisted. Medical treatment can dramatically reduce the severity of withdrawal symptoms and, in many cases, prevent them almost entirely. Medication-assisted treatment is the gold standard approach endorsed by every major medical organization worldwide. Buprenorphine (commonly prescribed as Suboxone, which combines buprenorphine with naloxone) is a partial opioid agonist that activates opioid receptors enough to prevent withdrawal and reduce cravings without producing the dangerous respiratory depression or euphoria of full agonist opioids. It can be prescribed in outpatient settings by qualified providers, making it widely accessible. Methadone is a full opioid agonist dispensed through licensed opioid treatment programs, most effective for people with severe, long-standing dependence who have not responded to other treatments. Naltrexone (Vivitrol) is an opioid antagonist that blocks the effects of opioids entirely and is used after the withdrawal phase is complete to prevent relapse. Beyond these primary medications, healthcare providers can prescribe additional comfort medications during withdrawal. Clonidine reduces anxiety, agitation, muscle aches, sweating, and runny nose. Loperamide manages diarrhea. Ondansetron or promethazine address nausea and vomiting. Non-addictive sleep aids can help with insomnia. Anti-inflammatory medications manage pain and muscle aches. The choice between outpatient and inpatient withdrawal management depends on the severity of dependence, the specific opioid used, the presence of co-occurring conditions, social support availability, and previous treatment history. Regardless of the setting, medically managed withdrawal combined with a plan for ongoing MAT, therapy, and support gives you the best possible foundation for long-term recovery. Tracking your progress through tools like Sobrius complements medical treatment by providing a personal, daily record of your healing journey.
Buprenorphine/Suboxone
A partial opioid agonist that reduces withdrawal severity and cravings. Can be prescribed in office-based settings. Research shows it reduces overdose deaths by over 50 percent when used as part of comprehensive treatment.
Methadone
A full opioid agonist dispensed through specialized clinics. Most effective for severe, long-term dependence. Eliminates withdrawal symptoms and reduces cravings when dosed appropriately. Requires daily clinic visits initially.
Naltrexone (Vivitrol)
An opioid antagonist that blocks opioid receptors entirely. Used after withdrawal is complete to prevent relapse. Available as a monthly injection, which improves adherence. Patient must be opioid-free for 7-14 days before initiation.
Comfort Medications
Clonidine for anxiety and autonomic symptoms, loperamide for diarrhea, ondansetron for nausea, NSAIDs for pain, and non-addictive sleep aids can all be used alongside primary treatment to manage specific withdrawal symptoms.
Inpatient vs. Outpatient Management
Inpatient withdrawal management provides 24-hour medical monitoring and is recommended for severe dependence, polysubstance use, or limited social support. Outpatient management with buprenorphine is appropriate for many patients and allows treatment in a less restrictive setting.
Helpful Resources
SAMHSA National Helpline
Free, confidential, 24/7, 365-day-a-year treatment referral and information service for individuals and families facing substance use disorders. Available in English and Spanish.
1-800-662-4357
Visit WebsiteSAMHSA Treatment Locator
A searchable directory of substance use disorder treatment facilities and programs across the United States. Find providers by location, treatment type, and insurance accepted.
Visit WebsiteNational Institute on Drug Abuse (NIDA)
Comprehensive, research-based information about opioid addiction, treatment options, and the science of recovery. NIDA funds and publishes the latest research on effective treatments for opioid use disorder.
Visit Website988 Suicide and Crisis Lifeline
Free, confidential crisis support available 24/7 by phone, chat, or text. If you or someone you know is in crisis during withdrawal or recovery, trained counselors are available to help immediately.
Call or text 988
Visit WebsiteFrequently Asked Questions
Find answers to common questions about recovery and sobriety.
Track your opioid-free days with Sobrius
Use Sobrius alongside your medical treatment to see your recovery progress grow, one day at a time. Free on the App Store and Google Play.